Dynamics in Post-pandemic Global Polycystic Kidney Disease Treatment Industry: Supply and Demand, Markets and Prices 2021-2027

Dynamics in Post-pandemic Global Polycystic Kidney Disease Treatment Industry: Supply and Demand, Markets and Prices 2021-2027

Report Code: KNJ663259 | No. of Pages: 129 | Category: Pharmaceuticals and Healthcare
Publisher: GRD Survey | Date of Publish: Mar-2021
Covid-19 has impacted the supply and demand status for many industries along the supply chain. In this report a comprehensive analysis of current global Polycystic Kidney Disease Treatment market in terms of demand and supply environment is provided, as well as price trend currently and in the next few years. Global leading players are profiled with their revenue, market share, profit margin, major product portfolio and SWOT analysis. This report also includes global and regional market size and forecast, major product development trend and typical downstream segment scenario, under the context of market drivers and inhibitors analysis. According to this survey, the global Polycystic Kidney Disease Treatment market is estimated to have reached $ xx million in 2020, and projected to grow at a CAGR of xx% to $ xx million in 2027.

Segmented by Category
ANG-3070

CIM-2

CR-8

Others

Segmented by End User/Segment
Clinic

Research Center

Hospital

Segmented by Country
North America
United States
Canada
Mexico
Europe
Germany
France
UK
Italy
Russia
Spain
Asia Pacific
China
Japan
Korea
Southeast Asia
India
Australasia
Central & South America
Brazil
Argentina
Colombia
Middle East & Africa
Iran
Israel
Turkey
South Africa
Saudi Arabia

Key manufacturers included in this survey
Mironid Ltd

Metabolic Solutions Development Company LLC

ManRos Therapeutics

Madrigal Pharmaceuticals Inc.

Kadmon Corp LLC

Ipsen SA

IC-MedTech Inc

Endocyte Inc

DiscoveryBiomed Inc

Conatus Pharmaceuticals Inc

Celgene Corp

Aptevo Therapeutics Inc

Angion Biomedica Corp



Table of Contents

1 Product Introduction and Overview
    1.1 Product Definition
    1.2 Product Specification
    1.3 Global Market Overview
        1.3.1 Global Polycystic Kidney Disease Treatment Market Status and Forecast (2016-2027)
        1.3.2 Global Polycystic Kidney Disease Treatment Sales Value CAGR by Region
    1.4 Market Drivers, Inhibitors
        1.4.1 Market Drivers
        1.4.2 Market Inhibitors
        1.4.3 COVID-19 Impact Analysis
2 Global Polycystic Kidney Disease Treatment Supply by Company
    2.1 Global Polycystic Kidney Disease Treatment Sales Value by Company
    2.2 Polycystic Kidney Disease Treatment Sales Area of Main Manufacturers
    2.3 Trend of Concentration Rate
3 Global and Regional Polycystic Kidney Disease Treatment Market Status by Category
    3.1 Polycystic Kidney Disease Treatment Category Introduction
        3.1.1 ANG-3070

        3.1.2 CIM-2

        3.1.3 CR-8

        3.1.4 Others
    3.2 Global Polycystic Kidney Disease Treatment Market by Category
    3.3 North America: by Category
    3.4 Europe: by Category
    3.5 Asia Pacific: by Category
    3.6 Central & South America: by Category
    3.7 Middle East & Africa: by Category
4 Global and Regional Polycystic Kidney Disease Treatment Market Status by End User/Segment
    4.1 Polycystic Kidney Disease Treatment Segment by End User/Segment
        4.1.1 Clinic

        4.1.2 Research Center

        4.1.3 Hospital
    4.2 Global Polycystic Kidney Disease Treatment Market by End User/Segment
    4.3 North America: by End User/Segment
    4.4 Europe: by End User/Segment
    4.5 Asia Pacific: by End User/Segment
    4.6 Central & South America: by End User/Segment
    4.7 Middle East & Africa: by End User/Segment
5 Global Polycystic Kidney Disease Treatment Market Status by Region
    5.1 Global Polycystic Kidney Disease Treatment Market by Region
    5.2 North America Polycystic Kidney Disease Treatment Market Status
    5.3 Europe Polycystic Kidney Disease Treatment Market Status
    5.4 Asia Pacific Polycystic Kidney Disease Treatment Market Status
    5.5 Central & South America Polycystic Kidney Disease Treatment Market Status
    5.6 Middle East & Africa Polycystic Kidney Disease Treatment Market Status
6 North America Polycystic Kidney Disease Treatment Market Status
    6.1 North America Polycystic Kidney Disease Treatment Market by Country
    6.2 United States
    6.3 Canada
    6.4 Mexico
7 Europe Polycystic Kidney Disease Treatment Market Status
    7.1 Europe Polycystic Kidney Disease Treatment Market by Country
    7.2 Germany
    7.3 France
    7.4 UK
    7.5 Italy
    7.6 Russia
    7.7 Spain
8 Asia Pacific Polycystic Kidney Disease Treatment Market Status
   8.1 Asia Pacific Polycystic Kidney Disease Treatment Market by Country
    8.2 China
    8.3 Japan
    8.4 Korea
    8.5 Southeast Asia
    8.6 India
    8.7 Australasia
9 Central & South America Polycystic Kidney Disease Treatment Market Status
    9.1 Central & South America Polycystic Kidney Disease Treatment Market by Country
    9.2 Brazil
    9.3 Argentina
    9.4 Colombia
10 Middle East & Africa Polycystic Kidney Disease Treatment Market Status
    10.1 Middle East & Africa Polycystic Kidney Disease Treatment Market by Country
    10.2 Iran
    10.3 Israel
    10.4 Turkey
    10.5 South Africa
    10.8 Saudi Arabia
11 Major Downstream Customers Analysis
    11.1 Customer One Analysis
    11.2 Customer Two Analysis
    11.3 Customer Three Analysis
    11.4 Customer Four Analysis
12 Global Polycystic Kidney Disease Treatment Market Forecast by Category and by End User/Segment
    12.1 Global Polycystic Kidney Disease Treatment Sales Value Forecast (2022-2027)
    12.2 Global Polycystic Kidney Disease Treatment Forecast by Category
    12.3 Global Polycystic Kidney Disease Treatment Forecast by End User/Segment
13 Global Polycystic Kidney Disease Treatment Market Forecast by Region/Country
    13.1 Global Polycystic Kidney Disease Treatment Market Forecast by Region (2022-2027)
    13.2 North America Market Forecast
    13.3 Europe Market Forecast
    13.4 Asia Pacific Market Forecast
    13.5 Central & South America Market Forecast
    13.6 Middle East & Africa Market Forecast
14 Key Participants Company Information
    14.1 Mironid Ltd

        14.1.1 Company Information
        14.1.2 Polycystic Kidney Disease Treatment Product Introduction
        14.1.3 Mironid Ltd
 Polycystic Kidney Disease Treatment Sales Value, Gross Margin and Global Share (2019-2021)
        14.1.4 SWOT Analysis
    14.2 Metabolic Solutions Development Company LLC

        14.2.1 Company Information
        14.2.2 Polycystic Kidney Disease Treatment Product Introduction
        14.2.3 Metabolic Solutions Development Company LLC
 Polycystic Kidney Disease Treatment Sales Value, Gross Margin and Global Share (2019-2021)
        14.2.4 SWOT Analysis
    14.3 ManRos Therapeutics

        14.3.1 Company Information
        14.3.2 Polycystic Kidney Disease Treatment Product Introduction
        14.3.3 ManRos Therapeutics
 Polycystic Kidney Disease Treatment Sales Value, Gross Margin and Global Share (2019-2021)
        14.3.4 SWOT Analysis
    14.4 Madrigal Pharmaceuticals Inc.

        14.4.1 Company Information
        14.4.2 Polycystic Kidney Disease Treatment Product Introduction
        14.4.3 Madrigal Pharmaceuticals Inc.
 Polycystic Kidney Disease Treatment Sales Value, Gross Margin and Global Share (2019-2021)
        14.4.4 SWOT Analysis
    14.5 Kadmon Corp LLC

        14.5.1 Company Information
        14.5.2 Polycystic Kidney Disease Treatment Product Introduction
        14.5.3 Kadmon Corp LLC
 Polycystic Kidney Disease Treatment Sales Value, Gross Margin and Global Share (2019-2021)
        14.5.4 SWOT Analysis
    14.6 Ipsen SA

        14.6.1 Company Information
        14.6.2 Polycystic Kidney Disease Treatment Product Introduction
        14.6.3 Ipsen SA
 Polycystic Kidney Disease Treatment Sales Value, Gross Margin and Global Share (2019-2021)
        14.6.4 SWOT Analysis
    14.7 IC-MedTech Inc

        14.7.1 Company Information
        14.7.2 Polycystic Kidney Disease Treatment Product Introduction
        14.7.3 IC-MedTech Inc
 Polycystic Kidney Disease Treatment Sales Value, Gross Margin and Global Share (2019-2021)
        14.7.4 SWOT Analysis
    14.8 Endocyte Inc

        14.8.1 Company Information
        14.8.2 Polycystic Kidney Disease Treatment Product Introduction
        14.8.3 Endocyte Inc
 Polycystic Kidney Disease Treatment Sales Value, Gross Margin and Global Share (2019-2021)
        14.8.4 SWOT Analysis
    14.9 DiscoveryBiomed Inc

        14.9.1 Company Information
        14.9.2 Polycystic Kidney Disease Treatment Product Introduction
        14.9.3 DiscoveryBiomed Inc
 Polycystic Kidney Disease Treatment Sales Value, Gross Margin and Global Share (2019-2021)
        14.9.4 SWOT Analysis
    14.10 Conatus Pharmaceuticals Inc

        14.10.1 Company Information
        14.10.2 Polycystic Kidney Disease Treatment Product Introduction
        14.10.3 Conatus Pharmaceuticals Inc
 Polycystic Kidney Disease Treatment Sales Value, Gross Margin and Global Share (2019-2021)
        14.10.4 SWOT Analysis
    14.11 Celgene Corp

    14.12 Aptevo Therapeutics Inc

    14.13 Angion Biomedica Corp

15 Conclusion
16 Methodology

NEED Help?

If you need any help or guidance, please feel free to call us.

USA : +1 (661) 636 6162

INDIA : +91 9325802062

or

Write us on : sales@kandjmarketresearch.com